The contract-research giant will help move Medigen’s broader enterovirus vaccine toward clinical trials, building on an EV71 shot already approved in Taiwan and Vietnam.
A large Swedish study tracked hundreds of thousands of people and found that those who actually completed a mailed stool test were far less likely to die of colorectal cancer.
C2N Diagnostics’ PrecivityAD2 measures amyloid and tau markers from a blood draw — part of a fast-moving shift away from expensive scans and spinal taps for Alzheimer’s diagnosis.
Scientists found lymph-node-like structures in skull bone marrow that spring into action against brain tumors — and a scalp gel that revs them up improved survival in mice.
In supercentenarians, a rare hybrid “killer-helper” T cell made up nearly a fifth of all T cells — hinting the immune system keeps adapting even in extreme old age.
The manufacturer will produce an AAV9 gene therapy for GM2 gangliosidosis — a group of fatal inherited disorders — developed with Queen’s University ahead of planned clinical trials.
Analyzing antibody “fingerprints” across thousands of people, a deep-learning model spotted markers that flag who is likely to mount a weak vaccine response in advance.
The revenue-cycle giant is adding an AI platform that files and clears insurer authorizations — targeting one of the most-hated bottlenecks in US healthcare.
Columbia engineers linked lab-grown human bone and lung tissue on a chip and watched circulating breast-cancer cells choose their targets — and soften them up in advance.
Researchers used AI to redesign antibody fragments so they can work inside cells — a long-standing hurdle — and aimed them at the toxic proteins behind Alzheimer’s, Parkinson’s and motor neurone disease.
The Dutch biotech will push its brain-signaling drug through a mid-stage trial for cognitive impairment in schizophrenia — a common, disabling problem with no approved treatment.
Ultragenyx’s Genglycos delivers a working gene to the liver in glycogen storage disease type Ia, aiming to free patients from the relentless routine of round-the-clock cornstarch dosing.